Old Web
English
Sign In
Acemap
>
authorDetail
>
David P. Schenkein
David P. Schenkein
Millennium Pharmaceuticals
Immunology
Medicine
Dexamethasone
Clinical trial
Bortezomib
4
Papers
452
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib
2007
Blood
George Mulligan
Constantine S. Mitsiades
Barb Bryant
Fenghuang Zhan
W. J. Chng
Steven Roels
Erik Koenig
Andrew Fergus
Yongsheng Huang
Paul G. Richardson
William L. Trepicchio
Annemiek Broyl
Pieter Sonneveld
John D. Shaughnessy
Leif Bergsagel
David P. Schenkein
Dixie Lee Esseltine
Anthony Boral
Kenneth C. Anderson
Show All
Source
Cite
Save
Citations (310)
Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myeloma.
2005
Cancer
James R. Berenson
Sundar Jagannath
Bart Barlogie
David T. Siegel
Raymond Alexanian
Paul G. Richardson
David Irwin
Melissa Alsina
S. Vincent Rajkumar
Gordon Srkalovic M.D.
Seema Singhal
Steven Limentani
Ruben Niesvizky
Dixie L. Esseltine
Elizabeth Trehu
David P. Schenkein
Kenneth Anderson
Show All
Source
Cite
Save
Citations (101)
Antibody-based therapeutics: Focus on prostate cancer
2005
Cancer and Metastasis Reviews
Jeffrey S Ross
Karen Gray
Iain J. Webb
Gary S. Gray
Mark Rolfe
David P. Schenkein
David M. Nanus
Mathew I. Millowsky
Neil H. Bander
Show All
Source
Cite
Save
Citations (41)
Targeting IKK Inhibits Multiple Myeloma (MM) Cell Growth in the Bone Marrow Microenvironment.
2004
Blood
Teru Hideshima
Pierfrancesco Tassone
Dharminder Chauhan
Kenji Ishitsuka
Constantine S. Mitsiades
Noopur Raje
Shaji Kumar
Makoto Hamasaki
Hiromasa Hideshima
Nikhil C. Munshi
Paul G. Richardson
David P. Schenkein
Kenneth C. Anderson
Show All
Source
Cite
Save
Citations (0)
1